| Ytd | 13.50% | |
| 1y | -30.55% |
| Open | 21.40 | Prev Close | 21.32 | Low | 21.38 | High | 21.95 | Mkt Cap | 11.20B |
| Vol | 5.34M | Avg Vol | 7.20M | EPS | -1.91 | P/E | N/A | Forward P/E | 10.78 |
| Beta | 0.64 | Short Ratio | 6.12 | Inst. Own | 106.35% | Dividend | 0.20 | Div Yield | 0.94 |
| Ex Div Date | 05-29 | Earning | 07-30 | 50-d Avg | 19.00 | 200-d Avg | 19.57 | 1yr Est | 21.54 |
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-positive-pre
Citigroup analyst Joanne Wuensch downgrades Baxter International (NYSE:BAX) from Neutral to Sell
Barclays analyst Matt Miksic maintains Baxter International (NYSE:BAX) with a Overweight and rais
Baxter tops earnings, but profit plunges 35% as tariffs and manufacturing costs rise; outlook for 20
Baxter International (NYSE:BAX) affirms FY2026 Adj EPS guidance from $1.85-$2.05 to $1.85-$2.05 vs $
Baxter International (NYSE:BAX) affirms FY2026 Adj EPS guidance from $1.85-$2.05 to $1.85-$2.05 vs $
Baxter Intl (NYSE:BAX) reported quarterly earnings of $0.37 per share which beat the analyst consens
Evercore ISI Group analyst Vijay Kumar maintains Baxter International (NYSE:BAX) with a Outperfor
Oil prices have risen. Here's how Strait of Hormuz tensions could soon increase healthcare costs
Baxter warns of an EU-wide ifosfamide shortage until next year after manufacturing disruption, with
https://www.ema.europa.eu/en/documents/other/medicine-shortage-communication-msc-holoxan-tronoxal-mi
Baxter Intl (NYSE:BAX) is looking for FY2026 Adj EPS of $1.85-$2.05 vs $2.25 analyst estimate. sees
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the departure of exec
Goldman Sachs analyst David Roman maintains Baxter International (NYSE:BAX) with a Neutral and lo
Barclays analyst Matt Miksic maintains Baxter Intl (NYSE:BAX) with a Overweight and lowers the pr
A volatile Thursday rattled Wall Street, with technology and software stocks sliding across the boar
Baxter shares plummeted more than 15% after the medical device maker missed profit estimates and iss
The U.S. Commerce Department, under the Trump administration, has launched a national security revie
The S&P 500 Index is up over 200% over the past decade, but 22 stocks have declined during that
Ten large-cap stocks, including Novo Nordisk and UPS, tumbled last week on weak earnings and guidanc
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.
Bausch + Lomb's efforts to sell have so far been unsuccessful. Meanwhile, KKR is aggressively pu
Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent d
Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly e
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear
Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company
DaVita Inc (NYSE: DVA), Fresenius Medical Care AG (NYSE: FMS), and Baxter International Inc (NYSE: B
U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losse
On Tuesday, 647 companies set new 52-week lows.
On Tuesday, 386 stocks made new 52-week lows.
Companies Reporting Before The Bell • SES AI (NYSE:SES) is projected to report quarterly earnings a
Benzinga